Lara Kujtan Selected Research

Lara Kujtan Research Topics

5	Neoplasms (Cancer) 01/2023 - 01/2018
2	Lung Neoplasms (Lung Cancer) 10/2023 - 02/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2023 - 01/2019
2	Carcinoma (Carcinomatosis) 01/2023 - 01/2018
1	Neoplasm Metastasis (Metastasis) 10/2023
1	Pericardial Effusion 10/2023
1	Colorectal Neoplasms (Colorectal Cancer) 10/2023
1	Abdominal Pain (Pain, Abdominal) 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 05/2019
1	Prostatic Neoplasms (Prostate Cancer) 05/2019
1	Nasopharyngeal Carcinoma 01/2019
1	Chronic Disease (Chronic Diseases) 01/2019
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2018
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018
1	Lymphoma (Lymphomas) 01/2018
1	Fabry Disease (Fabry's Disease) 01/2014

2	Tyrosine Kinase InhibitorsIBA 10/2023 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 10/2023 - 01/2019
1	osimertinibIBA 10/2023
1	Cell-Free Nucleic AcidsIBA 10/2023
1	AntibodiesIBA 10/2023
1	telisotuzumab vedotinIBA 08/2023
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Immune Checkpoint InhibitorsIBA 02/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2019
1	Rituximab (Mabthera)FDA Link 05/2019
1	GalactosylgalactosylglucosylceramidaseIBA 01/2014
1	GalactosidasesIBA 01/2014
1	globotriaosylceramide (globotriosylceramide)IBA 01/2014